Koray Aslan

ORCID: 0000-0002-3432-7381
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Endometriosis Research and Treatment
  • Cervical Cancer and HPV Research
  • Uterine Myomas and Treatments
  • Multiple and Secondary Primary Cancers
  • Colorectal and Anal Carcinomas
  • Pregnancy and Medication Impact
  • Drug Transport and Resistance Mechanisms
  • Radiomics and Machine Learning in Medical Imaging
  • Grief, Bereavement, and Mental Health
  • Intraperitoneal and Appendiceal Malignancies
  • Gastric Cancer Management and Outcomes
  • Viral-associated cancers and disorders
  • Cancer and Skin Lesions
  • Cultural and Sociopolitical Studies
  • Cancer Diagnosis and Treatment
  • Ovarian function and disorders
  • COVID-19 and healthcare impacts
  • Cancer Risks and Factors
  • Clinical Nutrition and Gastroenterology
  • Reproductive Health and Technologies
  • Effects of Radiation Exposure
  • Surgical site infection prevention
  • Salivary Gland Tumors Diagnosis and Treatment

Sağlık Bilimleri Üniversitesi
2019-2024

Ankara Onkoloji Eğitim ve Araştırma Hastanesi
2021-2024

Zekai Tahir Burak Kadın Sağlığı Eğitim ve Araştırma Hastanesi
2019-2023

Memorial Ankara Hospital
2021

University of Health Sciences
2019-2020

Women’s Health Care
2019-2020

University of Health Sciences Antigua
2020

University of Health Science
2019

Gynecologic Oncology Group
2019

Gazi University
2013-2017

10.1016/j.ijgc.2024.100721 article EN International Journal of Gynecological Cancer 2025-02-01

Objective:The aim of this study was to determine the prognostic value lymph node ratio (LNR) in women with 2018 International Federation Gynecology and Obstetrics stage IIIC cervical cancer.Methods: In retrospective dual-institutional study, a total 185 node-positive cancer patients who had undergone radical hysterectomy systematic pelvic paraaortic lymphadenectomy were included.All received adjuvant chemoradiation after surgery.LNR defined as positive nodes (LNs) number LNs removed.The...

10.3802/jgo.2020.31.e1 article EN cc-by-nc Journal of Gynecologic Oncology 2019-06-26

Introduction The purposes of this study were to compare adjuvant treatment modalities and determine prognostic factors in stage III endometrioid endometrial cancer (EC). Methods SATEN was a retrospective involving 13 centers from 10 countries. Patients who had been operated on between 1998 2018 diagnosed with EC analyzed. Results A total 990 women identified; 317 IIIA, 18 IIIB, 655 IIIC diseases. median follow-up 42 months. 5-year disease-free survival (DFS) patients by modality 68.5% for...

10.1136/ijgc-2019-000643 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2019-09-02

The risk of ovarian malignancy is increasing in patients with a history breast cancer. Thus, well-defined predictors should be identified to determine surgical or conservative management adnexal masses women This study aimed clarify the malignant tumors cancer an isolated mass.

10.1177/00031348241265145 article EN The American Surgeon 2024-07-21

To study the occurrence of bacterial translocation and to assess impact breastfeeding on in animal model necrotizing enterocolitis.A total 20 neonate Sprague-Dawley rats were enrolled study. Rats randomly allocated into either control or group just after birth. Ten newborn left with their mother be breast-fed. In contrary, enterocolitis consisted neonates that separated from mothers, housed an incubator gavaged a special rodent formula three times daily. Survival rates, weight changes,...

10.4149/bll_2012_047 article EN Bratislavské lekárske listy/Bratislava medical journal 2012-01-01

Objective The purpose of this retrospective study was to define a risk index that would serve as surrogate marker lymphovascular space invasion (LVSI) in women with endometrioid endometrial cancer (EC). Materials and Methods Final pathology reports 498 who underwent surgery curative intent for EC between January 2008 June 2018 were retrospectively reviewed. Logistic regression used investigate clinicopathologic factors associated positive LVSI status. Independent build model “risk index”...

10.1097/pgp.0000000000000596 article EN International Journal of Gynecological Pathology 2019-04-27

<h3>Introduction/Background</h3> Objective: The objective of this study was to determine the cervical cancer burden in Turkey during a nation-based screening program. <h3>Methodology</h3> Methods: database Turkish Ministry Health searched order identify all consecutive patients 1st Jan 2019 and 31th Dec for retrospective, nationwide, cohort study. incidence 3-year overall survival were investigated. <h3>Results</h3> Results: With an age-standardized 4.2/100.000, is 10th most common among...

10.1136/ijgc-2023-esgo.160 article EN other-oa 2023-09-01

<h3>Introduction/Background</h3> Objective: The aim of this study was to determine the prognostic value lymph node ratio (LNR) in women with 2018 International Federation Gynecology and Obstetrics stage IIIC (p) cervical cancer. <h3>Methodology</h3> Methods: In retrospective multicenter study, a total 335 node-positive cancer patients who had undergone radical hysterectomy systematic pelvic para-aortic lymphadenectomy were included. All received adjuvant chemoradiation after surgery. LNR...

10.1136/ijgc-2023-esgo.171 article EN other-oa 2023-09-01

<h3>Introduction/Background</h3> Carcinoma vulva is a rare disease accounting for 1.3% of all gynecological malignancies. The aim the present study to analyze clinicopathological characteristics women with squamous and glandular cell carcinoma who underwent primary surgical management. <h3>Methodology</h3> A retrospective analysis was conducted on 649 patients were treated at multicenter in Turkey. <h3>Results</h3> mean age 63.2 ± 12.8 years. most common location lateral (55.5%) then midline...

10.1136/ijgc-2023-esgo.828 article EN other-oa 2023-09-01

Giriş: Endometrial kanserinde, nüks riski olan hastaları belirlemek ve adjuvan tedavi kullanımına rehberlik etmek amacı ile klinik-patolojik prognostik faktörler kullanılarak risk grupları oluşturulmuştur. Güncel yayınlanan rehberde yeni bir grubu tanımlanmış olup evre I endometrioid karsinom, grade 1-2 hastalık LVSI pozitif olgular myometrial invazyon derinliğinden bağımsız olarak “orta-yüksek” riskli sınıflandırılmıştır. Bu retrospektif çalışmanın IA yüksek-orta endometrial kanserli...

10.16948/zktipb.585846 article TR Zeynep Kamil Tıp Bülteni 2019-08-29
Coming Soon ...